Allena Pharmaceuticals Inc. plans to raise $92 million through an initial public offering of common stock.
The Newton, Mass.-based biotech company granted underwriters a 30-day option to buy additional common shares at the offering price.
According to its prospectus, Allena Pharmaceuticals applied to list the shares on the Nasdaq Global Market under the symbol ALNA.
Credit Suisse Securities (USA) LLC, Jefferies LLC, Cowen and Co. LLC and Wedbush Securities Inc. are acting as underwriters for the offering.